Joseph Wu
Präsident bei American Heart Association, Inc.
Profil
Joseph C.
Wu is the founder of Stem Cell Theranostics, Inc. founded in 2013.
He is currently the President & Director at American Heart Association, Inc. Dr. Wu holds a doctorate degree from the University of California, Los Angeles and Yale University.
Aktive Positionen von Joseph Wu
Unternehmen | Position | Beginn |
---|---|---|
American Heart Association, Inc.
American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services American Heart Association, Inc. operates a voluntary health organization funded by private contributions. The organization offers services for coronary heart diseases and strokes, high blood cholesterol & physical inactivity, obesity, and diabetes. The company was founded in 1924 and is headquartered in Dallas, TX. | Präsident | - |
Ehemalige bekannte Positionen von Joseph Wu
Unternehmen | Position | Ende |
---|---|---|
Stem Cell Theranostics, Inc.
Stem Cell Theranostics, Inc. BiotechnologyHealth Technology Stem Cell Theranostics, Inc. develops genetically-targeted therapies for genetic and drug-induced heart disease. It offers a discovery platform that focuses on the generation and use of stem cell-derived, patient-specific cardiac models in drug screening and therapeutic development. The company was founded by Andrew Lee, Robert C. Robbins, Divya Nag, and Joseph C. Wu in 2013 and is headquartered in Redwood City, CA. | Gründer | - |
Ausbildung von Joseph Wu
University of California, Los Angeles | Doctorate Degree |
Yale University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
American Heart Association, Inc.
American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services American Heart Association, Inc. operates a voluntary health organization funded by private contributions. The organization offers services for coronary heart diseases and strokes, high blood cholesterol & physical inactivity, obesity, and diabetes. The company was founded in 1924 and is headquartered in Dallas, TX. | Commercial Services |
Stem Cell Theranostics, Inc.
Stem Cell Theranostics, Inc. BiotechnologyHealth Technology Stem Cell Theranostics, Inc. develops genetically-targeted therapies for genetic and drug-induced heart disease. It offers a discovery platform that focuses on the generation and use of stem cell-derived, patient-specific cardiac models in drug screening and therapeutic development. The company was founded by Andrew Lee, Robert C. Robbins, Divya Nag, and Joseph C. Wu in 2013 and is headquartered in Redwood City, CA. | Health Technology |